UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 147

Sortiert nach

Profiles of liver fibrosis evolution during long‐term tenofovir treatment in HIV‐positive patients coinfected with hepatitis B

Liver international, 2021-12, Vol.41 (12), p.2874-2884

2021

Volltextzugriff (PDF)

Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection

Journal of medical virology, 2019-04, Vol.91 (4), p.630-641

2019

Volltextzugriff (PDF)

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine

Hepatology (Baltimore, Md.), 2018-06, Vol.67 (6), p.2468-2470

2018

Volltextzugriff (PDF)

Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV–HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study

Journal of the International AIDS Society, 2017-02, Vol.20 (1), p.21426-n/a

2017

Volltextzugriff (PDF)

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients

Journal of hepatology, 2016-10, Vol.65 (4), p.683-691

2016

Volltextzugriff (PDF)

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

AIDS (London), 2006-01, Vol.20 (2), p.F1-F7

2006

Volltextzugriff (PDF)

Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

American journal of respiratory and critical care medicine, 2008-01, Vol.177 (1), p.108-113

2008

Volltextzugriff (PDF)

Detectable HIV-RNA in semen of HIV controllers

PloS one, 2017-08, Vol.12 (8), p.e0183376-e0183376

2017

Volltextzugriff (PDF)

Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles

PloS one, 2016-08, Vol.11 (8), p.e0160251-e0160251

2016

Volltextzugriff (PDF)

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART[S]

Journal of lipid research, 2015-03, Vol.56 (3), p.692-702

2015

Volltextzugriff (PDF)

Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients

Journal of hepatology, 2009-06, Vol.50 (6), p.1074-1083

2009

Volltextzugriff (PDF)

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts

PloS one, 2013-08, Vol.8 (8), p.e71473-e71473

2013

Volltextzugriff (PDF)

High incidence of treatment‐induced and vaccine‐escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B–infected patients

Hepatology (Baltimore, Md.), 2013-09, Vol.58 (3), p.912-922

2013

Volltextzugriff (PDF)

High Concentration of Raltegravir in Semen of HIV-Infected Men: Results from a Substudy of the EASIER-ANRS 138 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.937-939

2010

Volltextzugriff (PDF)

HIV-1 group N: travelling beyond Cameroon

The Lancet (British edition), 2011-11, Vol.378 (9806), p.1894-1894

2011

Volltextzugriff (PDF)

Switch from Enfuvirtide to Raltegravir Lowers Plasma Concentrations of Darunavir and Tipranavir: a Pharmacokinetic Substudy of the EASIER-ANRS 138 Trial

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3613-3615

2011

Volltextzugriff (PDF)

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial

Journal of antimicrobial chemotherapy, 2022-08, Vol.77 (9), p.2506-2515

2022

Volltextzugriff (PDF)

Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study

Travel medicine and infectious disease, 2019-05, Vol.29, p.40-47

2019

Volltextzugriff (PDF)

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients

AIDS (London), 2015-09, Vol.29 (14), p.1821-1830

ANRS CO13 HEPAVIH Cohort

2015

Volltextzugriff (PDF)

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

AIDS (London), 2006-01, Vol.20 (2), p.F1-F7

2006

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(146)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Profiles of liver fibrosis evolution during long‐term tenofovir treatment in HIV‐positive patients coinfected with hepatitis B

Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine

Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV–HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection

Detectable HIV-RNA in semen of HIV controllers

Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART[S]

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts

High incidence of treatment‐induced and vaccine‐escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B–infected patients

High Concentration of Raltegravir in Semen of HIV-Infected Men: Results from a Substudy of the EASIER-ANRS 138 Trial

HIV-1 group N: travelling beyond Cameroon

Switch from Enfuvirtide to Raltegravir Lowers Plasma Concentrations of Darunavir and Tipranavir: a Pharmacokinetic Substudy of the EASIER-ANRS 138 Trial

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial

Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

Suchergebnisse filtern